Systemic Lupus Erythematosus

Why trials studying Systemic Lupus Erythematosus stopped, in this sample of ClinicalTrials.gov.

18 stopped trials with a clear reason; 89% ended for non-scientific reasons.

Trials

• A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus
  NCT06429800 · WITHDRAWN · funding business
  “Financial”
• A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)
  NCT06456567 · WITHDRAWN · funding business
  “Sponsor business decision”
• A Study of Imvotamab in Severe Systemic Lupus Erythematosus
  NCT06041568 · TERMINATED · funding business
  “Company Decision.”
• A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)
  NCT05306574 · TERMINATED · funding business
  “Business decision”
• A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus
  NCT05123586 · TERMINATED · futility
  “Study terminated due to lack of efficacy”
• Effect of Curcumin on Systemic Lupus Erythematosus
  NCT03953261 · TERMINATED · funding business
  “COVID and lack of support staff 2. lack of support staff to conduct the study”
• LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE
  NCT04141046 · TERMINATED · funding business
  “Terminated due to end of funding period.”
• Tissue Sodium in Autoimmune Disease
  NCT02525835 · WITHDRAWN · funding business
  “funding”
• Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)
  NCT03159936 · TERMINATED · slow accrual
  “unable to identify additional subjects to qualify for enrollment”
• Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus
  NCT02917265 · TERMINATED · slow accrual
  “poor recruitment”
• Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus
  NCT02533570 · TERMINATED · funding business
  “Sponsor decision based on portfolio prioritization”
• Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
  NCT01946880 · TERMINATED · slow accrual
  “Slow enrollment.”
• Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
  NCT01781611 · TERMINATED · slow accrual
  “Slow recruitment”
• The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria
  NCT00508898 · WITHDRAWN · funding business
  “Funding problem; trial abandoned.”
• Myfortic Versus Azathioprine in Systemic Lupus Erythematosus
  NCT00504244 · TERMINATED · slow accrual
  “Insufficient recruitment”
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
  NCT00430677 · TERMINATED · futility
  “Terminated due to failure to meet the primary efficacy endpoint in the Short-term Period”
• Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases
  NCT00849745 · TERMINATED · slow accrual
  “low accrual”
• Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
  NCT02408471 · TERMINATED · funding business
  “Business Priorities”

Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.